Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe Cases
Beta-adrenoceptor Activation Reduces Host Viral Resistance by Preventing IFN-γ Production in Liver NK Cells
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe CasesFebruary 6, 2021
β2-Adrenoceptor-Mediated Upregulation of IL-17 May Contribute to Pulmonary Immunopathology in COVID-19: Does Blockade of IL-17 and β-Adrenergic Effects Hold a Therapeutic Potential?April 9, 2020
Neuroendocrine Immune Implications in Rheumatoid Arthritis and Polymyalgia Rheumatica: Past and Present Unresolved Issues and Optimising Glucocorticoid TreatmentDecember 8, 2018
Neuroendocrine Immunology in 2014 – What Was Hot and Some Conceptual Trends as Presented on BrainImmuneJanuary 8, 2015
